Home › Graft-Versus-Host Disease › Georgia
Graft-Versus-Host Disease clinical trials in Georgia
5 studies for Graft-Versus-Host Disease are looking for participants at sites in Georgia.
Cities in Georgia
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Emory University, Atlanta
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Blood and Marrow Transplant Group of Georgia, Atlanta
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
- Children's Healthcare of Atlanta, Atlanta
RecruitingPhase 2
Ages 2 and older · All sexes · Updated May 11, 2026 · NCT04380740A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Emory University Winship Cancer Institute, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
- Emory University, Atlanta
RecruitingObservational study
36 Months · All sexes · Updated Oct 20, 2025 · NCT05866302From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.